Managing bronchiolitis in pediatric patients: Current evidence
Background: Acute bronchiolitis is an inflammatory process affecting small airways. Although most cases are self-limiting, it is still one of the most common causes of hospitalization below 24 months of age. Treatment is mainly supportive. The purpose of this narrative review was to look for recent...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Jaypee Brothers Medical Publisher
2022-01-01
|
Series: | Indian Journal of Respiratory Care |
Subjects: | |
Online Access: | http://www.ijrc.in/article.asp?issn=2277-9019;year=2022;volume=11;issue=4;spage=291;epage=295;aulast=Dhal |
_version_ | 1797697914948026368 |
---|---|
author | Subhranshu Sekhar Dhal Hiremath Sagar |
author_facet | Subhranshu Sekhar Dhal Hiremath Sagar |
author_sort | Subhranshu Sekhar Dhal |
collection | DOAJ |
description | Background: Acute bronchiolitis is an inflammatory process affecting small airways. Although most cases are self-limiting, it is still one of the most common causes of hospitalization below 24 months of age. Treatment is mainly supportive. The purpose of this narrative review was to look for recent evidence in the management of bronchiolitis. Methods: PubMed, EMBASE, Global Health, MEDLINE, SCOPUS, and Cochrane database searches were performed using keywords such as bronchiolitis, management, bronchodilators, nebulized epinephrine, corticosteroids, and hypertonic saline. Systematic reviews, original articles, and clinical practice guidelines with evidence for bronchiolitis management were included during our search. We excluded guidelines and clinical trials which solely focused on high-risk children, articles by a single author, and trials that are not part of a clinical practice guideline. Discussion: The safety and efficacy of various therapies for bronchiolitis such as bronchodilators, epinephrine, hypertonic saline, and corticosteroid were analyzed. Bronchodilators have not shown consistent benefits in bronchiolitis and may be tried in the selected population. Current evidence does not suggest routine use of nebulized epinephrine in bronchiolitis except as rescue therapy in selected cases. Hypertonic saline showed positive results in some studies but questions still remain regarding its effectiveness in all. Recent trials also do not support the use of systemic or inhaled corticosteroids in bronchiolitis. Conclusion: In conclusion, there is no strong evidence to routinely recommend the use of bronchodilator, epinephrine, hypertonic saline, or corticosteroids in acute bronchiolitis. Supportive care still remains the mainstay of therapy for bronchiolitis. |
first_indexed | 2024-03-12T03:46:46Z |
format | Article |
id | doaj.art-b0c138abfa9844d4bca6542809311170 |
institution | Directory Open Access Journal |
issn | 2277-9019 2321-4899 |
language | English |
last_indexed | 2024-03-12T03:46:46Z |
publishDate | 2022-01-01 |
publisher | Jaypee Brothers Medical Publisher |
record_format | Article |
series | Indian Journal of Respiratory Care |
spelling | doaj.art-b0c138abfa9844d4bca65428093111702023-09-03T12:43:45ZengJaypee Brothers Medical PublisherIndian Journal of Respiratory Care2277-90192321-48992022-01-0111429129510.4103/ijrc.ijrc_153_22Managing bronchiolitis in pediatric patients: Current evidenceSubhranshu Sekhar DhalHiremath SagarBackground: Acute bronchiolitis is an inflammatory process affecting small airways. Although most cases are self-limiting, it is still one of the most common causes of hospitalization below 24 months of age. Treatment is mainly supportive. The purpose of this narrative review was to look for recent evidence in the management of bronchiolitis. Methods: PubMed, EMBASE, Global Health, MEDLINE, SCOPUS, and Cochrane database searches were performed using keywords such as bronchiolitis, management, bronchodilators, nebulized epinephrine, corticosteroids, and hypertonic saline. Systematic reviews, original articles, and clinical practice guidelines with evidence for bronchiolitis management were included during our search. We excluded guidelines and clinical trials which solely focused on high-risk children, articles by a single author, and trials that are not part of a clinical practice guideline. Discussion: The safety and efficacy of various therapies for bronchiolitis such as bronchodilators, epinephrine, hypertonic saline, and corticosteroid were analyzed. Bronchodilators have not shown consistent benefits in bronchiolitis and may be tried in the selected population. Current evidence does not suggest routine use of nebulized epinephrine in bronchiolitis except as rescue therapy in selected cases. Hypertonic saline showed positive results in some studies but questions still remain regarding its effectiveness in all. Recent trials also do not support the use of systemic or inhaled corticosteroids in bronchiolitis. Conclusion: In conclusion, there is no strong evidence to routinely recommend the use of bronchodilator, epinephrine, hypertonic saline, or corticosteroids in acute bronchiolitis. Supportive care still remains the mainstay of therapy for bronchiolitis.http://www.ijrc.in/article.asp?issn=2277-9019;year=2022;volume=11;issue=4;spage=291;epage=295;aulast=Dhalbronchiolitisbronchodilatorepinephrinehypertonic saline |
spellingShingle | Subhranshu Sekhar Dhal Hiremath Sagar Managing bronchiolitis in pediatric patients: Current evidence Indian Journal of Respiratory Care bronchiolitis bronchodilator epinephrine hypertonic saline |
title | Managing bronchiolitis in pediatric patients: Current evidence |
title_full | Managing bronchiolitis in pediatric patients: Current evidence |
title_fullStr | Managing bronchiolitis in pediatric patients: Current evidence |
title_full_unstemmed | Managing bronchiolitis in pediatric patients: Current evidence |
title_short | Managing bronchiolitis in pediatric patients: Current evidence |
title_sort | managing bronchiolitis in pediatric patients current evidence |
topic | bronchiolitis bronchodilator epinephrine hypertonic saline |
url | http://www.ijrc.in/article.asp?issn=2277-9019;year=2022;volume=11;issue=4;spage=291;epage=295;aulast=Dhal |
work_keys_str_mv | AT subhranshusekhardhal managingbronchiolitisinpediatricpatientscurrentevidence AT hiremathsagar managingbronchiolitisinpediatricpatientscurrentevidence |